Tumour necrosis factor (TNF) receptor family in GtoPdb v.2023.1

Abstract


Dysregulated TNFR signalling is associated with many inflammatory disorders, including some forms of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases and for cancer immunotherapy [5, 6, 49].

DOI: https://doi.org/10.2218/gtopdb/F334/2023.1
Published
26-Apr-2023
How to Cite
MacEwan, D. (2023) “Tumour necrosis factor (TNF) receptor family in GtoPdb v.2023.1”, IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi: 10.2218/gtopdb/F334/2023.1.
Issue
Vol 2023 No 1 (2023)
Section
Summaries
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.